We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Urinary Biomarkers Perform Better Than Serum Biomarkers in Detection of Specific Diseases

By LabMedica International staff writers
Posted on 02 Nov 2023
Print article
Image: Urine biomarkers can outperform serum biomarkers in certain diseases (Photo courtesy of Xue C, et al.)
Image: Urine biomarkers can outperform serum biomarkers in certain diseases (Photo courtesy of Xue C, et al.)

The focus in biomarker research has largely been on blood-based markers. Yet, blood markers don't provide a complete picture of clinically relevant indicators. As a result, urine has proved to be a significant and additional source of information for diagnosis. Its diagnostic power, especially for certain conditions, is gaining recognition, sometimes even surpassing that of blood biomarkers. Now, a new study has shed light on the enhanced ability of urinary biomarkers to detect diseases compared to plasma biomarkers.

The study by a group of researchers, including scientists from the Shanghai Changzheng Hospital (Shanghai, China), has revealed that urine biomarkers might be better than serum biomarkers at detecting some illnesses. Blood is a complex mix that remains fairly stable due to the body's homeostatic mechanisms. Urine, on the other hand, varies more because it is a byproduct of kidney filtration and does not need to maintain a stable state. This variability means it can indicate changes occurring in the body more accurately.

During urine production in the kidney's nephrons, biomarkers specific to the urinary system can become more concentrated than in blood. Smaller molecules that aren't reabsorbed after the kidney's filtration become more concentrated in the urine, making them easier to identify. The simplicity and non-invasive nature of collecting urine also make it appealing for biomarker research. Plus, proteins in urine can be preserved for a long time without degrading. Despite these advantages, the researchers recognize hurdles like standardizing urine biomarker tests and expanding the range of illnesses detectable through urine.

“The direct association between urine and the urinary system positions it as a prime area for discovering biomarkers, particularly in the context of urological diseases,” said Dr. Cheng Xue from the Shanghai Changzheng Hospital. “A key takeaway from our findings is the potential for a combined approach, leveraging both urinary and serum biomarkers for a more holistic and personalized strategy for disease diagnosis and management.”

Related Links:
Shanghai Changzheng Hospital

Platinum Supplier
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Gold Supplier
Turbidimetric Control
D-Dimer Turbidimetric Control
Complement 3 (C3) Test
GPP-100 C3 Kit
Motorized Pipette Controller

Print article


Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Molecular Diagnostics

view channel
Image: The PrismRA blood test helps target best treatments for patients with rheumatoid arthritis (Photo courtesy of Scipher Medicine)

Groundbreaking Rheumatoid Arthritis Blood Test Predicts Treatment Response

Rheumatoid arthritis (RA), an autoimmune disease affecting joints and other systems in the body, impacts millions globally. Typically, the initial biologic treatment involves anti-inflammatory drugs from... Read more


view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more


view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more


view channel
Image: Current testing methods for antibiotic susceptibility rely on growing bacterial colonies in the presence of antibiotics (Photo courtesy of 123RF)

Rapid Antimicrobial Susceptibility Test Returns Results within 30 Minutes

In 2019, antimicrobial resistance (AMR) was responsible for the deaths of approximately 1.3 million individuals. The conventional approach for testing antimicrobial susceptibility involves cultivating... Read more


view channel
Image: The acquisition significantly expands Medix Biochemica’s portfolio of IVD raw materials (Photo courtesy of ViroStat)

Medix Biochemica Acquires US-Based ViroStat to Expand Infectious Diseases Antibody Offering

Medix Biochemica (Espoo, Finland), a supplier of critical raw materials to the in vitro diagnostics (IVD) industry, has acquired ViroStat LLC (Portland, ME, USA), a provider of infectious disease antibodies... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.